SEC Form 4 · accession 0001607062-16-000899
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 11, 2016
Accepted (ET)
Jul 11, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 6, 2016 | A | 20,186 | $5.00 | A | 3,750,185 | I | See Note |
| Common StockF1 | Jul 6, 2016 | A | 23,173 | $5.00 | A | 3,773,358 | I | See Note |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1AFH Holding & Advisory, LLC is the record holder of the shares of Common Stock. Mr. Heshmatpour is sole member of AFH Holding and has sole voting and investment control over the shares of Common Stock held by AFH Holding & Advisory, LLC and may therefore be deemed the beneficial owner of such shares.